Antiretroviral therapy among people with HIV with comorbidities in the United States: a retrospective cohort study [0.03%]
美国共病HIV人群中的抗逆转录病毒治疗：一项回顾性队列研究
Erin K Buysman,Princy Kumar,Kimberly McNiff et al.
Erin K Buysman et al.
Objectives: To describe patterns of antiretroviral medications among people with HIV (PWH) who also have common comorbid conditions in a United States cohort. ...
Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE Trial [0.03%]
一项关于赞布替尼单药治疗与伊布替尼单药治疗复发/难治性慢性淋巴细胞白血病和小淋巴细胞淋巴瘤患者相关的健康相关生活质量结果的ALPINE试验结果研究报告
Constantine S Tam,Nicole Lamanna,Susan M O&#x;Brien et al.
Constantine S Tam et al.
Objective: The purpose of this analysis was to assess health-related quality of life (HRQoL) in patients treated with zanubrutinib and ibrutinib in the ALPINE trial (NCT03734016). ...
Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab [0.03%]
新型布鲁顿酪氨酸激酶抑制剂泽布替尼与苯达莫司汀利妥昔单抗治疗初治慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者生活质量的比较研究
Paolo Ghia,Gisoo Barnes,Keri Yang et al.
Paolo Ghia et al.
Objective: Zanubrutinib is a highly selective, next-generation Bruton's tyrosine kinase inhibitor. In the phase 3 SEQUOIA trial (NCT03336333), treatment with zanubrutinib resulted in significantly improved progression-fre...
Monthly variations in acute coronary syndromes outcomes during the first year of the COVID-19 pandemic [0.03%]
2019冠状病毒病大流行第一年急性冠脉综合征月变化特征分析
Abdulmajeed Alharbi,Halah Alfatlawi,Clarissa Pena et al.
Abdulmajeed Alharbi et al.
Background: Cardiovascular disease, particularly acute coronary syndromes (ACS), is the leading cause of death in the United States. Minor fluctuations in hospital admissions for different conditions, including ACS, can b...
The incremental cost of non-alcoholic steatohepatitis and type 2 diabetes in the United States using real-world data [0.03%]
基于真实世界数据的美国非酒精性脂肪肝病和2型糖尿病的增量成本分析
Jesse Fishman,Elliot B Tapper,Stephen Dodge et al.
Jesse Fishman et al.
Background: Non-alcoholic steatohepatitis (NASH) and type 2 diabetes (T2D) are both linked to substantial healthcare costs and are often co-occurring. We aim to quantify the incremental cost of NASH and T2D using real-wor...
Ercüment Öztürk,Sencer Ganidağlı,Zeynel Abidin Öztürk
Ercüment Öztürk
Objectives: We aimed to investigate the risk factors of colistin-associated nephrotoxicity in patients older than 65 years treated in the palliative care unit. ...
Interdisciplinary collaboration in the diagnosis and management of chronic cough: the role and importance of primary care providers [0.03%]
慢性咳嗽的诊断与治疗中的跨学科协作：基层医疗提供者的重要作用
Peter V Dicpinigaitis,Kenneth W Altman,Isil Ulger Isci et al.
Peter V Dicpinigaitis et al.
Chronic cough (CC) is associated with many conditions, so identifying contributing causes poses a diagnostic challenge. However, guidelines written for US physicians do not explicitly outline suggested roles for primary care providers (PCPs...
Cold polypectomy techniques for small and diminutive colorectal polyps: a systematic review and network meta-analysis of randomized controlled trials [0.03%]
冷热技术切除小型和微小结肠息肉的系统评价和网络meta分析
Mohamed Abuelazm,Ahmed K Awad,Islam Mohamed et al.
Mohamed Abuelazm et al.
Objective: In the management of small and diminutive polyps, cold polypectomy is favored over electrocautery polypectomy. However, the optimal cold polypectomy technique is still controversial. Hence, this review aims to ...
Ivy leaf dry extract EA 575 for the treatment of acute and chronic cough in pediatric patients: review and expert survey [0.03%]
儿童急慢性咳嗽应用 Ivy 子叶干提取物EA 575治疗的专家调查及文献回顾
Georg Seifert,Laura Upstone,Christopher P Watling et al.
Georg Seifert et al.
Objectives: EA 575 (Prospan) is a herbal medicine containing a dried extract of ivy leaves (drug extract ratio 5-7.5:1; extraction solvent, 30% ethanol). Although widely used for the treatment of cough, there remains a la...
Correction [0.03%]
改正
Published Erratum
Current medical research and opinion. 2023 Oct;39(10):I. DOI:10.1080/03007995.2023.2257985 2023